The National Committee's U.S.-China Track II Dialogue on Healthcare, established in 2017, examines the effectiveness of the healthcare systems in China and the United States and recommends ways to better measure and manage the delivery and efficiency of healthcare in the two countries.
Dr. Vanda Felbab-Brown and Mr. Ben Westhoff discuss the production and trafficking of fentanyl, bilateral efforts to curb the supply, and the prospects for progress.
Lessons Learned Amid a Pandemic: How the United States and China can Collaborate on Global Health Crises
A moderated discussion featuring five track II healthcare dialogue participants (three American, two Chinese), on the current state of and key takeaways from the COVID-19 pandemic, as well as main points from the most recent U.S.-China Track II Dialogue on Healthcare.
Dr. Elanah Uretsky reveales the business and networking practices of Chinese businessmen and officials, and the associated risks of contracting HIV/AIDS and other sexually transmitted diseases.